Press Releases
Successful completion of development of a precision therapeutic system designed to safely achieve high concentration of chemotherapeutic in target organ, via non-circulatory pathways and with little to no systemic drug exposure and associated toxicity. Cary, NC October 25, 2023 —…
RALEIGH, N.C. (November 1, 2022): Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, today announced the appointment of Michael Aldridge as the Company’s…
The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer. Read More
Raleigh, NC, June 30th, 2020 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company focused on developing iontophoresis drug delivery devices, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent 10,695,562 B2. Embodiments…
Raleigh, NC, March 20th, 2020 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company developing the ACT Implantable Iontophoresis Chemotherapy Delivery Device with gemcitabine (ACT-IOP-003), announced today that the Company has submitted an investigational new drug (IND) application to…
Raleigh, NC, August 30th, 2019 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company focused on developing iontophoresis drug delivery devices, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for…
Raleigh, NC, August 22nd, 2019 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company focused on developing iontophoresis drug delivery devices, today announced receipt of a $771,376 grant from the National Cancer Institute of the National Institutes of Health…
Raleigh, NC, September 28th, 2018 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company focused on developing iontophoresis drug delivery devices, today announced receipt of a $1,111,364 grant from the National Cancer Institute of the National Institutes of Health…
